Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JP9Y | ISIN: DK0060336014 | Ticker-Symbol: NZM2
Tradegate
25.04.24
10:54 Uhr
52,04 Euro
-0,02
-0,04 %
1-Jahres-Chart
NOVONESIS A/S Chart 1 Jahr
5-Tage-Chart
NOVONESIS A/S 5-Tage-Chart
RealtimeGeldBriefZeit
52,0452,2412:21
52,0452,1812:20

Aktuelle News zur NOVONESIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.04.Novozymes A/S: Invitation to the annual shareholders' meeting476
08.04.Novozymes A/S: Share-based legacy RSU program granted292
27.03.NASDAQ OMX Nordic: Change of name and ticker code for Novozymes (97/24)256The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024 approved a secondary name of the company Novonesis A/S. As a consequence of the name change, Novozymes has...
► Artikel lesen
22.03.Novonesis showcased mood support probiotic at Expo West: MindAble 1714 targets gut-brain axis16
21.03.Novozymes A/S: 2024 outlook and pro forma financials48
18.03.Novozymes A/S: Novonesis will host a conference call regarding 2024 outlook and 2023 pro forma financials on March 2116
18.03.Biotalys NV: Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG454Press release - inside information Biotalys and Novonesis have entered into an agreement to advance EVOCA NG - the next generation of Biotalys' product candidate EVOCA* - to the final stage of development.Pending...
► Artikel lesen
12.03.FMC Canada to distribute Novonesis biosolutions in 202520
08.03.NASDAQ OMX Nordic: Anticipated change of name and ticker code for Novozymes (67/24)429The Extraordinary General Meeting (EGM) of Novozymes A/S (Novozymes) held on March 4, 2024, approved a secondary name of the company Novonesis A/S. As a consequence, Novozymes has changed its stock...
► Artikel lesen
05.03.Nasdaq Copenhagen A/S: Novozymes A/S - change of share name to Novonesis (Novozymes)B326The changes below will take effect on Nasdaq Copenhagen as per 6 March 2024. ISIN: DK0060336014 ------------------------------------------------ Name Novozymes B ...
► Artikel lesen
04.03.Novozymes A/S: Resolutions from the Extraordinary Shareholders' Meeting 2024285Company Announcement no. 10 March 4, 2024Today an extraordinary shareholders' meeting was conducted. The following resolutions were made: Adoption of Novonesis A/S as secondary name and amendment...
► Artikel lesen
09.02.Invitation to an extraordinary shareholders' meeting of Novozymes A/S30
02.02.Novonesis emerges from Chr. Hansen-Novozymes merger: The new company offers enzymes, microbial technologies and ingredients43
02.02.Novozymes A/S: Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed383Settlement of the combination of Novozymes and Chr. Hansen Holding successfully completed February 2, 2024Company announcement No. 07 On January 29, 2024, following the satisfaction of all...
► Artikel lesen
01.02.Recap: Novozymes Q4 Earnings32
01.02.Novozymes A/S: Legacy Novozymes delivers solid last full-year results456Legacy Novozymes is delivering solid growth and earnings in a year characterized by changing market demands, with 6% organic sales growth in Q4 and 5% organic sales growth in 2023. This marks the...
► Artikel lesen
31.01.Novozymes A/S: Total number of voting rights and capital on January 31, 20247
29.01.Novozymes A/S: Trading by management and close relations of management8
29.01.NASDAQ OMX Nordic: Derivatives: No adjustment in Chr. Hansen Holding due to merger with Novozymes (20/24)358The Boards of Directors of Chr. Hansen Holding A/S (Chr. Hansen Holding) and Novozymes A/S (Novozymes) have announced today about the completion of the combination of the two companies through a merger...
► Artikel lesen
29.01.Jefferies sees above peer growth for Novozymes, ups to 'buy'24
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1